ANNX
Price
$6.50
Change
-$0.18 (-2.69%)
Updated
Jan 15, 11:10 AM (EDT)
Capitalization
995.69M
53 days until earnings call
Intraday BUY SELL Signals
CRNX
Price
$54.35
Change
-$1.07 (-1.93%)
Updated
Jan 15, 11:19 AM (EDT)
Capitalization
5.69B
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANNX vs CRNX

Header iconANNX vs CRNX Comparison
Open Charts ANNX vs CRNXBanner chart's image
Annexon
Price$6.50
Change-$0.18 (-2.69%)
Volume$7.03K
Capitalization995.69M
Crinetics Pharmaceuticals
Price$54.35
Change-$1.07 (-1.93%)
Volume$2.1K
Capitalization5.69B
ANNX vs CRNX Comparison Chart in %
ANNX
Daily Signal:
Gain/Loss:
CRNX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANNX vs. CRNX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Hold and CRNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ANNX: $6.68 vs. CRNX: $55.42)
Brand notoriety: ANNX and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 148% vs. CRNX: 53%
Market capitalization -- ANNX: $995.69M vs. CRNX: $5.69B
ANNX [@Biotechnology] is valued at $995.69M. CRNX’s [@Biotechnology] market capitalization is $5.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANNX and CRNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 4 TA indicator(s) are bullish while CRNX’s TA Score has 4 bullish TA indicator(s).

  • ANNX’s TA Score: 4 bullish, 4 bearish.
  • CRNX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ANNX and CRNX are a good buy in the short-term.

Price Growth

ANNX (@Biotechnology) experienced а +20.80% price change this week, while CRNX (@Biotechnology) price change was +3.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

ANNX is expected to report earnings on Mar 09, 2026.

CRNX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($5.69B) has a higher market cap than ANNX($996M). ANNX YTD gains are higher at: 33.068 vs. CRNX (19.055). ANNX has higher annual earnings (EBITDA): -216.47M vs. CRNX (-474.16M). CRNX has more cash in the bank: 1.09B vs. ANNX (189M). ANNX has less debt than CRNX: ANNX (26.9M) vs CRNX (49.1M). CRNX has higher revenues than ANNX: CRNX (1.54M) vs ANNX (0).
ANNXCRNXANNX / CRNX
Capitalization996M5.69B18%
EBITDA-216.47M-474.16M46%
Gain YTD33.06819.055174%
P/E RatioN/AN/A-
Revenue01.54M-
Total Cash189M1.09B17%
Total Debt26.9M49.1M55%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
41
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANNXCRNX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 16 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signal:
Gain/Loss:
CRNX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECOIX10.840.05
+0.46%
Redwheel Next Generation Power InfrasIns
OILVX20.310.06
+0.30%
Optimum Large Cap Value Instl
PQIAX42.190.10
+0.24%
Principal Equity Income A
BGATX13.70-0.09
-0.68%
Baillie Gifford Global Alpha Equities 2
UGPIX27.88-0.58
-2.04%
ProFunds UltraChina Inv

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with RLAY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
+7.92%
RLAY - ANNX
42%
Loosely correlated
+1.64%
NRIX - ANNX
42%
Loosely correlated
+0.58%
SYRE - ANNX
41%
Loosely correlated
+5.17%
CRNX - ANNX
41%
Loosely correlated
+2.04%
VYGR - ANNX
41%
Loosely correlated
+2.74%
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+2.04%
XNCR - CRNX
59%
Loosely correlated
+3.66%
RVMD - CRNX
54%
Loosely correlated
+1.06%
IDYA - CRNX
51%
Loosely correlated
+5.53%
CLDX - CRNX
50%
Loosely correlated
+1.58%
KURA - CRNX
50%
Loosely correlated
+1.63%
More